NCT01304667

Chemo- and Radiotherapy in Epithelial Vulvar Cancer

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 1,618 (actual)
• Sponsor: AGO Study Group · Academic / Other
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This retrospective, multicenter study is designed to collect tumor characteristics as well as treatment data from patients diagnosed with primary or recurrent squamous cell cancer of the vulva with emphasis on indication and application of radio- and chemotherapy. Application of chemotherapy in primary treatment of vulvar cancer is rare; the study collective is therefore extended to relapsed disease.

Detailed description

All patients with primary squamous cell cancer of the vulva \> stage Ia who were diagnosed and received treatment between 1998 and 2008 at the participating centres will be included in the study. Furthermore patients with recurrent disease diagnosed and treated at the participating centres during the same time period can be included given that they not only underwent surgical excision for treatment. For centers with restricted resources for data entry an alternative study collective was defined: All Patients with primary or relapsed squamous cell vulvar cancer receiving radio- and/or chemotherapy for treatment at the participating centres between 1998 and 2008 will be included in the study. This also includes node negative patients receiving radio/chemotherapy for other reasons. The participating centers themselves have to decide which study collective they are documenting, dependent on their available resources.

Conditions

• Radio/Chemotherapy in Node Positive Advanced Vulvar Cancer

Timeline

• Start date: 2011-02-01
• Primary completion: 2012-06-01
• Completion: 2012-06-01
• First posted: 2011-02-25
• Last updated: 2016-05-10

Locations

1 site across 1 country: Germany